๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

ELEVATED LEVELS OF SERUM SECRETONEURIN IN PATIENTS WITH THERAPY RESISTANT CARCINOMA OF THE PROSTATE

โœ Scribed by ISCHIA, RUDOLF; HOBISCH, ALFRED; BAUER, RICHARD; WEISS, ULRIKE; GASSER, RUDOLF W.; HORNINGER, WOLFGANG; BARTSCH, GEORG; FUCHS, DIETMAR; BARTSCH, GEORG; WINKLER, HANS; KLOCKER, HELMUT; FISCHER-COLBRIE, REINER; CULIG, ZORAN

Book ID
122932991
Publisher
Lippincott Williams and Wilkins
Year
2000
Tongue
English
Weight
61 KB
Volume
163
Category
Article
ISSN
0022-5347

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Elevation of cytokine levels in cachecti
Elevation of cytokine levels in cachectic patients with prostate carcinoma
โœ Jesco Pfitzenmaier; Robert Vessella; Celestia S. Higano; Jennifer L. Noteboom; D ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 98 KB

## Abstract ## BACKGROUND Approximately 60โ€“70% of patients with advanced prostate carcinoma (CaP) suffer from cachexia, one of the most devastating conditions associated with advanced malignant disease. The pathophysiology of cachexia is multifactorial, and several cytokines, such as tumor necrosi

Elevated levels of serum aldolase A in p
Elevated levels of serum aldolase A in patients with renal cell carcinoma
โœ Takashi, M. ;Zhu, Y. ;Nakano, Y. ;Miyake, K. ;Kato, K. ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Springer ๐ŸŒ English โš– 371 KB

To clarify whether serum aldolase A is a useful biomarker for renal cell carcinoma (RCC), we determined serum levels of the aldolase A isozyme by an enzyme immunoassay in patients suffering from RCC, other urological tumors, and benign urological diseases. Forty-six of 126 patients with RCC (37%) ha